aXess and new directions for vascular access grafts

2022-04-08T16:50:57+01:00April 8th, 2022|Latest News|

Renal Interventions dedicated a feature article to arteriovenous grafts (AVG) for hemodialysis access, in which Xeltis’ restorative AVG graft aXess is prominently discussed among promising novel devices in vascular access. According to RI, aXess is a “futuristic implant—a graft [...]

Vascular experts discuss aXess in dialysis patients

2022-01-12T13:34:19+01:00January 12th, 2022|Latest News|

Matteo Tozzi, MD, vascular surgeon and professor of vascular surgery at Università dell’Insubria in Italy, and Frans L. Moll, MD, PhD, professor emeritus of vascular surgery at the University Medical Center Utrecht in The Netherlands, provided insights on the progress of the aXess trial in an [...]

Xeltis hires VP for Heart Valves

2021-12-13T12:41:35+01:00December 13th, 2021|Latest News|

The Xeltis Executive Team has been joined by seasoned medtech business leader David Mester as Vice-President, Business Lead, Valve. David has over 30 years of experience in structural heart devices and dedicated his career to advancing innovative materials and [...]

Go to Top